TGFB1 and neoplasm: In contrast, selectively activated M2-TAMs can promote tumor progression by maintaining tumor cell viability and promoting angiogenesis and invasion through the expression of soluble mediators (e.g., ARG1 derivatives and TGFβ) as well as surface receptors (e.g., programmed death ligand 1 (PD-L1)) 18.